What does NovoCure Ltd. do?

Jun 22 2025 06:40 PM IST
share
Share Via
NovoCure Ltd. is a small-cap oncology company focused on developing cancer treatments using TTFields technology. As of March 2025, it reported net sales of $155 million and a net loss of $34 million.
Overview:
NovoCure Ltd. is a commercial-stage oncology company engaged in developing cancer treatments using a therapy called TTFields, operating within the Pharmaceuticals & Biotechnology industry and categorized as a small-cap company.

Financial Snapshot:
Most recent Net Sales: 155 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -34 Million (Quarterly Results - Mar 2025)
Market-cap: USD 1,943.19 Million (Small Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.76
Return on Equity: -45.10%
Price to Book: 5.37

Contact Details:
Address: Forum, NO. 4 Grenville Street, SAINT HELIER None: JE2 4UF
Tel: 44 1534 756700
Website: https://www.novocure.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is NovoCure Ltd. technically bullish or bearish?
Sep 20 2025 07:42 PM IST
share
Share Via
Is NovoCure Ltd. overvalued or undervalued?
Sep 20 2025 06:18 PM IST
share
Share Via
Is NovoCure Ltd. overvalued or undervalued?
Jun 25 2025 08:55 AM IST
share
Share Via
Is NovoCure Ltd. technically bullish or bearish?
Jun 25 2025 08:46 AM IST
share
Share Via
Who are in the management team of NovoCure Ltd.?
Jun 22 2025 10:29 PM IST
share
Share Via